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Abstract 
Biofilm formation by pathogenic bacteria is one of the major threats in hospital related infections, hence inhibiting 
and eradicating biofilms has become a primary target for developing new anti-infection approaches. The present 
study was aimed to develop novel antibiofilm agents against two Gram-positive bacteria; Staphylococcus aureus (ATCC 
43300) and Streptococcus mutans (ATCC 25175) using gold nanomaterials conjugated with 3-(diphenylphosphino)
propionic acid (Au-LPa). Gold nanomaterials with different sizes as 2–3 nm small and 9–90 nm (50 nm average size) 
large were stabilized by LPa via different chemical synthetic strategies. The nanomaterials were fully characterized 
using atomic force microscope (AFM), transmission electron microscope, ultraviolet–visible absorption spectroscopy, 
and Fourier transformation infrared spectroscopy. Antibiofilm activity of Au-LPa nanomaterials was tested using LPa 
alone, Au-LPa and unprotected gold nanomaterials against the both biofilm-producing bacteria. The results showed 
that LPa alone did not inhibit biofilm formation to a significant extent below 0.025 mM, while conjugation with gold 
nanomaterials displayed manifold enhanced antibiofilm potential against both strains. Moreover, it was also observed 
that the antibiofilm potency of the Au-LPa nanomaterials varies with size variations of nanomaterials. AFM analysis 
of biofilms further complemented the assay results and provided morphological aspects of the antibiofilm action of 
Au-LPa nanomaterials.
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Introduction
Nanotechnology offers exceptional approaches towards 
controlling a variety of pivotal biological processes and 
is believed to have an influence on several biological 
systems since they also occur at the nanometer dimen-
sion. Applications of nanotechnology in medicine are 
immense and have paved the way for the development 
of new and effective medical treatments (i.e., nanomedi-
cine) (Emerich and Thanos 2003). The monitoring of 
size and structure at the nanoscale ensures advantages 
of nano-medicines over conventional therapies due to 
targeted drug delivery, enhanced bioavailability and bio-
conjugation (Geethalakshmi and Sarada 2013).
Microorganisms in general possess an extraordinary 
ability to settle and survive in precisely programmed 
regions of hosts and cause malfunction in biological 
routine. On the other hand, bacterial infections due to 
emerging multidrug-resistant (MDR) and the lack of 
development of new and effective drugs represent a dev-
astating problem in healthcare. MDR bacteria contribute 
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to morbidity and mortality rates in many of the com-
mon infectious diseases (Franci et  al. 2015). Staphylo-
coccus aureus is known to exfoliate the epidermal layers 
and localizes within the skin causing wound infections, 
while it can also penetrate lungs, bloodstream, joints, 
and bones in some extreme cases (Chwalibog et al. 2010). 
Whereas, production of extracellular polysaccharides and 
acids from dietary sugar and adhesion to dental enamel 
are amongst the most common clinically important fea-
tures of Streptococcus mutans that causes oral cavities 
and tooth decay (Choi et al. 2001).
Biofilms are microbes bound together in an extracel-
lular matrix of polymeric substances. These are simply 
characterized by irreversibly attached bacterial cells to 
any surface or to each other (Davey and O’toole 2000). 
The morphology and physiological characteristics of 
biofilm producing microorganisms adapt resistance up 
to 1000 times against antimicrobial agents in contrast 
to their planktonic counterparts (Mah et al. 2003). Vari-
ous pathogens tend to produce biofilms on food and/or 
storage surfaces, while some pathogenic bacteria such 
as Methicillin resistant Staphylococcus aureus (MRSA), 
Escherichia coli, Klebsiella pneumoniae and Pseudomonas 
species contribute majorly in nosocomial infections in 
hospitals on implanted medical devices, especially cath-
eter related urinary tract infections (CAUTIs) (Bryers 
2008). According to reports from national institute of 
health (NIH), biofilm infections are suggested to exceed 
by 60% in the developed world alone (Lewis 2001). There-
fore, it is imperative to develop novel antibiofilm agents 
for inhibition and eradication of already formed biofilms. 
Recently, metal and metal oxide nanoparticles have been 
found to be a useful alternate to inhibit microbial growth 
and prevent biofilm formation (Dhandapani et  al. 2012; 
Mu et al. 2016). Several antibiotics coated with metallic 
nanoparticles have recently been reported to produce 
interesting antibiofilm and antibacterial effects (Ahmed 
et al. 2016; Singh et al. 2014).
Inorganic nanoparticles are well known to interact 
with microorganisms and thus act as antibacterial and 
antifungal agents (Rai et  al. 2009; Taglietti et  al. 2014). 
Gold nanoparticles have presented tremendous applica-
tions in almost every field of science especially in biology. 
Grace and Pandian have reported the use of gold nano-
particles as a carrier of aminoglycosidic antibiotics like 
streptomycin, gentamycin and neomycin. Their results 
demonstrated high efficacy of gold nanocomposites of 
these drugs against various Gram-negative and Gram-
positive bacteria (Grace and Pandian 2007). Nanopar-
ticles interaction with bacteria is dependent on various 
factors including the size, morphology and coating of the 
nanoparticles. The antibacterial activity of the nanopar-
ticles has been found to alter vastly with modification 
in size of nanoparticles (Boda et  al. 2015; Martinez-
Castanon et al. 2008).
The aim of this study was to determine the influence of 
particle size of gold nanomaterials capped with 3-(diphe-
nylphosphino)propionic acid on bacterial biofilms of 
S. aureus (ATCC 43300) and S. mutans (ATCC 25175). 
AFM studies were also carried out to study the morpho-
logical changes occurred after treatment of small and 
large size gold nanomaterials.
Materials and methods
All chemicals and solvents were used as purchased 
without any purification or pretreatment unless 
stated otherwise. Tetrachloroauric acid  (HAuCl4), 
chloro(triphenylphosphine)gold(I) {Au(PPh3)Cl}, borane-
t-butylamine complex (BTBC), sodium borohydride 
 (NaBH4) and ligand 3-(diphenylphosphino)propionic 
acid (LPa) were purchased from Sigma-Aldrich (St. 
Louis, USA). All the solvents used were either HPLC or 
analytical grade, and were de-aerated according to stand-
ard protocols prior to use.
Synthesis of Au‑LPa large
Synthesis of Au-LPa nanoparticles involves the reduc-
tion of  HAuCl4 by  NaBH4 in the presence of LPa as sta-
bilizer. Briefly,  NaBH4 (0.015  mg in 0.1  mL deionized 
water) was added to a vigorously stirred  HAuCl4 solution 
(3.94 mg in 95 mL deionized water) and LPa (0.143 mg in 
5 mL deionized water and 0.5 mL of methanol) at room 
temperature. A reddish pink color solution was formed, 
showing a surface plasmon resonance (SPR) absorption 
peak at 524  nm confirms the formation of gold nano-
particle. The colloidal suspension was subjected to cen-
trifugation at 10,000  rpm to separate the nanoparticles 
from unreacted reagents especially toxic reducing agent 
and salt produced. Nanoparticles pellet was obtained as 
a result of centrifugation and was then re-suspended in 
water.
Synthesis of Au‑LPa small
The synthetic procedure used for Au-LPa nanoclusters 
was as previously described (Woodworth et  al. 2016). 
Precisely, the mixture of 1 mol equiv. of Au(PPh3)Cl and 
phosphine ligand LPa was taken in a de-aerated metha-
nol in an oven dried Schlenk flask under argon atmos-
phere. Vigorous stirring was continued and BTBC was 
added with 5 mol equiv. as compared to the gold precur-
sor. Following this, the reaction mixture turned to orange 
within 1 h. Further stirring was continued for 4 h to make 
sure the reaction was completed. Products obtained were 
characterized by UV–visible spectrophotometry, and 
TEM. Nanoclusters were also subjected to the same post 
synthesis treatment as described above.
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Synthesis of gold nanomaterials control (unprotected)
Both small and large gold nanomaterials alone used as 
controls were synthesized as described above and at simi-
lar concentrations in the absence of stabilizing agent LPa.
Biofilm inhibition potential of compounds
Antibiofilm activities of the Au-LPa nanomaterials were 
screened against the two bacterial strains using crys-
tal violet method as described previously (Ahmed et  al. 
2016). Biofilm inhibition was evaluated by using follow-
ing equation:
Biofilms imaging via atomic force microscope (AFM)
The antibiofilm potential of test samples against S. 
mutans (ATCC 25175) and S. aureus (ATCC 43300) 
was further studied by atomic force microscopic images 
analysis. Nanomaterials at concentrations 0.0025  mM 
were used for AFM analysis. Biofilm formation was car-
ried out in 24-well plate containing 8 mm circular cover 
slips. After incubation the cover slips were heat fixed 
and scanned by atomic force microscope (Agilent 5500). 
ACAFM mode was used with triangular shape silicon 
nitride soft cantilever (Veeco, model MLCT-AUHW) for 
AFM analysis.
Results
Characterization of Au‑LPa nanomaterials
Gold nanomaterials formation by reduction of metal ion 
in the presence of LPa was determined using UV–vis-
ible spectroscopy (Fig. 1). Au-LPa nanoparticles revealed 
absorbance maxima at 524 nm which is the characteris-
tic absorbance for un-aggregated colloidal suspension of 
gold nanoparticles. While the orange color and absorp-
tion maxima at lower wavelength for gold nanomaterials 
correspond to the smaller particle size, particularly less 
than 2  nm which is in agreement with our previously 
reported method for the size selective synthesis of gold 
nanoclusters (Woodworth et al. 2016).
Size determination of the Au‑LPa nanomaterials
Atomic force microscopic studies of Au-LPa large were 
performed through tapping mode atomic force micros-
copy in order to determine the particle size and mor-
phology of these nanoparticles. As depicted in Fig. 2, the 
nanoparticles were poly-dispersed, spherical in shape 
and their size ranged from 9 to 90  nm with an average 
size of 50 nm. While Au-LPa small were prepared by our 
previously optimized size selective synthesis ensuring the 
particle size in the range of 2–3 nm as shown in the TEM 
image (Fig. 2c).
% biofilm inhibition
=
{
(O.D. in control −O.D. of test)/O.D. in control
}
× 100
FT‑IR analysis
FT-IR analysis of Au-LPa and LPa alone was also carried 
out in order to determine the functionalities found in 
ligand that are responsible for the stabilization of nano-
materials (Fig. 3). Both the phosphine and carboxylic acid 
functionalities were found to be responsible for capping 
gold nanomaterials. The FT-IR spectrum of LPa shows 
four distinct absorption bands that appear at 3406 cm−1 
which corresponds to the OH group, another appears at 
2922 cm−1 because of CH stretching vibration. Carbonyl 
stretching vibration appears at 1720  cm−1 and Phos-
phorous Carbon bond vibration appears at 1407  cm−1. 
Following nanoparticles formation, distinct changes 
were visible in the FT-IR spectrum. An absorption band 
appearing at 3406  cm−1 shifted to 3419  cm−1, and a 
bend appeared due to carbonyl group vibration moved 
to 1633  cm−1. Bands appearing due to phosphorus and 
carbon bond stretching shifted to 1384 cm−1 and became 
more intense which suggests the stabilizing interaction of 
phosphine group with gold nanomaterials. These results 
are also consistent with previous reports, as phosphines 
and hydroxyl groups have been extensively used for metal 
nanoparticles preparation with narrow size distribution 
and higher stability (Wu et al. 2006).
Stability of Au‑LPa nanomaterials
pH effects on the stability of Au-LPa were also evaluated 
to test the robustness of the synthetic procedure. Fig-
ure 4a shows that nanoparticles were found to be stable 
in a pH range from 1 to 10 as evident from the UV–vis-
ible spectra since there is no effect of change in pH on 
nanoparticle absorption intensity as well as on its posi-
tion and no aggregation was noticed in the whole pH 
range.
Heat effects on the stability of Au-LPa were also evalu-
ated as shown in Fig. 4b, and it was found that nanopar-
ticles were stable upon heating up to 100 °C. However, a 
slight change in peak intensity of the nanoparticles was 
observed while the peak position remains the same with 
a little peak broadening which may correspond to a tiny 
proportion of particle aggregation. Hence Au-LPa nano-
materials were found to tolerate the alteration in the pH 
and temperature conditions, which suggests that they 
are quite stable and can be utilized in a vast variety of 
applications.
Antibiofilm activity
% inhibition was determined for LPa solution and Au-
LPa large and small against S. aureus (ATCC 43300) 
and S. mutans (ATCC 25175) biofilms using the crystal 
violet method. The biofilms were treated with four con-
centrations of all test samples at a level of 0.025, 0.0125, 
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0.00625, 0.003125  mM for 24  h. Results of the antibi-
ofilm assay are presented in Fig.  5. Organic LPa ligand 
did not exert significant antibiofilm activity, however 
interestingly when conjugated with gold nanomaterials, 
significant effects were observed in antibiofilm potential. 
Moreover, Au-LPa small were found to be more efficient 
in inhibiting the biofilms of both tested Gram-positive 
bacteria as compared to their large counterparts. Proper 
controls for both small and large gold nanomaterials were 
also tested to negate false positive results, but both con-
trols are found to be inactive or only slightly active at 
similar concentrations as compared to Au-LPa.
Atomic force microscopy analysis for the imaging 
of biofilms
Biofilm inhibitory potential of the synthesized gold 
nanomaterials (small and large) of LPa was further 
complimented with atomic force microscopic analysis. 
a
b
Fig. 1 UV–visible spectrum of Au-LPa nanomaterials. a Au-LPa large show surface plasmon resonance band at 524 nm. b Au-LPa small show char-
acteristic absorption signal at 418 nm
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Biofilm inhibition was observed after treating the cells 
with 0.0025 mM concentration of the synthesized nano-
particle, LPa, gold nanomaterials alone (small and large) 
and compared with controls. In the case of S. aureus 
Au-LPa small completely inhibited biofilm formation, 
Au-LPa large showed partial inhibition whereas gold 
nanomaterials (small and large) and LPa alone failed to 
inhibit biofilm formation (Fig.  6a–f). On the contrary, 
Au-LPa small and large completely inhibited the biofilm 
formation of S. mutans as compared to gold nanomateri-
als (small and large) and LPa alone (Fig. 7a–f).
Discussion
After reduction of gold salts with corresponding reduc-
ing agents in the presence of LPa, Au-LPa nanomateri-
als were fully characterized by UV–visible, FT-IR, AFM, 
and TEM. Both large and small Au-LPa nanomaterials 
revealed characteristic surface plasmon resonance band 
corresponding to their sizes as supported by previous 
literature.
After the successful synthesis and characterization 
of both Au-LPa nanomaterials, these were subjected to 
antibiofilms assay via the crystal violet method against 
S. aureus and S. mutans. The results suggest that LPa 
alone did not inhibit the formation of both bacteria 
biofilms to a significant level at the tested concentra-
tions. In particular, it had negative effect on the inhibi-
tion of S. mutans biofilms, while minimal positive effects 
on S. aureus biofilms were observed (21.18% inhibition 
only at high dose of 0.025  mM). Au-LPa nanomaterials 
on the other hand showed high tendency to inhibit the 
biofilm formation of both bacteria. Au-LPa small dis-
played 95–96% inhibition against both bacteria even at 
low concentration (0.003125  mM), and had no change 
in increasing the sample’s concentration. Contrary to 
Au-LPa small, Au-LPa large inhibited S. mutans to great 
extent even at lower concentrations but showed dose 
dependent response towards inhibiting S. aureus biofilms 
(54–84% inhibition at 0.003125–0.025  mM). To nullify 
the false positive results from Au-LPa nanomaterials, 
effect of gold controls (unprotected) was also evaluated 
by similar protocol and parameters. Both gold nanoma-
terials controls were freshly synthesized as described in 
“Materials and methods” section and were used with-
out any pretreatment or proper characterization. Both 
gold nanomaterials controls are found to be ineffective 
at the concentration levels where Au-LPa nanomaterials 
showed significant inhibition, however at higher doses 
both controls showed positive % inhibition against both 
bacteria. These results can be attributed towards the tox-
icity of borane reducing agents whose concentration is 
much higher in the control samples at higher doses, since 
they were used as prepared. Hence such an effect was 
expected and completely justifiable.
The higher activity and lower selectivity of Au-LPa 
small as compared to Au-LPa large may be attributed 
to the impact of smaller size. Since the smaller size of 
Fig. 2 Size and morphology of Au-LPa nanomaterials. a AFM image 
of Au-LPa large. b Size distribution histogram of Au-LPa large. c TEM 
image of Au-LPa small
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nanoclusters guarantees the delivery of therapeutic agent 
inside the cells by overcoming the membrane barri-
ers more effectively and as a result causes better activity 
(Martinez-Castanon et al. 2008).
AFM analysis of the antibiofilms assay further pro-
vided a clear picture of the mode of action of these test 
samples. After the biofilm formation, the AFM images of 
control samples indicated prominent and integrated bio-
film surface topology of both the tested bacterial strains, 
i.e. S. aureus, S. mutans (Figs.  6a, 7a respectively). Fig-
ures 6b and 7b shows that the biofilms of both bacteria 
treated with Au-LPa small were completely diminished as 
Fig. 3 FT-IR spectra of (a) ligand LPa, (b) Au-LPa large nanomaterials
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was expected from the high % inhibition, hence no signs 
of bacteria were found in the Au-LPa small treated sam-
ples. The Au-LPa large treated samples displayed reduced 
biofilm as compared to controls, but significant presence 
of partially depleted biofilm can be observed in Fig.  6c 
for S. aureus as large nanomaterials have less efficiency 
to penetrate the compact biofilm. However, Au-LPa large 
selectively disintegrated S. mutans biofilms as compared 
to S. aureus (Fig. 7c), which was forecasted in the assay 
results (Fig. 5). It is suggested in the recent literature that 
antibiofilms activity of nanoparticles might be the result 
of nanoparticle approach the biofilm resident through 
water channel (Stewart 2003). Biofilms samples were then 
also treated with the unprotected gold nanomaterials 
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(both large and small) to check their antibiofilm effect 
and validate the results of Au-LPa nanomaterials. Fig-
ures 6d, e and 7d, e represent gold controls treated bio-
film images, and it is clearly evident from these images 
that at lower concentrations gold controls have no anti-
biofilm potential. Same was the case with LPa alone, as it 
induced no damages to the compactness of biofilms. So 
based on above discussion it is safe to conclude that the 
conjugation of gold enhanced the antibiofilm efficacy of 
LPa, while small Au-LPa nanomaterials are found to be 
more effective against both Gram-positive bacteria bio-
films as compared to larger nanoparticles.
Since the potential of any antimicrobial agent to per-
meate biofilms and to disperse it is of great importance, 
and nanomaterials have provided a great deal of feasi-
bility to overcome this problem more recently. Thus, 
our results demonstrate that Au-LPa nanomaterials can 
be a useful candidate to disrupt Gram-positive bacteria 
biofilms with several advantages over the antibiotics 
approach. Phosphines are a newer class of compounds 
which are not being used quite extensively for antibac-
terial purpose, hence there is less chance for bacterial 
resistance. However, phosphine gas has been used in 
fumigation for pest control purposes due to its known 
toxicity.
In conclusion, gold nanomaterials of different sizes 
(2–3 nm and 50 nm) coated with LPa were prepared via 
two different chemical methodologies. Au-LPa nanoma-
terials showed enhanced in vitro inhibition of biofilms of 
Gram-positive bacteria S. aureus (ATCC 43300) and S. 
mutans (ATCC 25175) as compared to the same concen-
tration of LPa alone (0.0025 mM). This clearly indicates 
that gold nanomaterials conjugation with labile phos-
phine ligands can display antibiofilm effects. The results 
of the antibiofilm assay and AFM analysis demonstrated 
that Au-LPa small nanomaterials inhibited the biofilms 
Fig. 5 Percent biofilm inhibition of Au-LPa (small and large size) against (a, b) S. aureus; (c, d) S. mutans. Statistical significance of the data was 
represented as *p < 0.05, **p < 0.01 and ***p < 0.001. Whereas * represent significance as compared to LPa and # represent as compared to gold 
nanomaterials alone (small or large size)
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more efficiently in comparison to Au-LPa large. Due to 
the important proposition of Gram-positive bacteria 
biofilms in human pathogenesis, and their antibacterial 
resistance, this method provides a useful candidate of 
interest for the applications in nanobiotechnology. How-
ever, more studies including evaluation of the toxicity 
Fig. 6 AFM topographic images of S. aureus biofilms; a biofilm untreated; b Au-LPa small treated; c Au-LPa large treated; d gold nanomaterials large 
control treated; e gold nanomaterials small control treated; f LPa alone treated
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profile of Au-LPa nanomaterials and their mechanism of 
action are our future plans.
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